Xuanyi Du

528 total citations
17 papers, 356 citations indexed

About

Xuanyi Du is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Xuanyi Du has authored 17 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 8 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Xuanyi Du's work include Chronic Kidney Disease and Diabetes (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Protease and Inhibitor Mechanisms (3 papers). Xuanyi Du is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Protease and Inhibitor Mechanisms (3 papers). Xuanyi Du collaborates with scholars based in China, Japan and India. Xuanyi Du's co-authors include Akira Shimizu, Yukinari Masuda, Yuh Fukuda, Toshio Akimoto, Naomi Kuwahara, Akiko Mii, Emiko Fujita, Tomohiro Kaneko, Yasuhiko Iino and Takashi Arai and has published in prestigious journals such as Scientific Reports, Annals of Oncology and International Journal of Biological Macromolecules.

In The Last Decade

Xuanyi Du

16 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuanyi Du China	8	120	108	95	88	65	17	356
Taichi Murakami Japan	13	173 1.4×	83 0.8×	234 2.5×	71 0.8×	91 1.4×	44	522
Xiangcheng Xie China	10	84 0.7×	69 0.6×	101 1.1×	101 1.1×	51 0.8×	20	362
Mengjie Jiang China	12	66 0.6×	91 0.8×	71 0.7×	131 1.5×	101 1.6×	35	381
Qiuju Wei China	12	159 1.3×	76 0.7×	130 1.4×	31 0.4×	58 0.9×	33	384
Motokazu Matsuura Japan	13	190 1.6×	81 0.8×	195 2.1×	144 1.6×	59 0.9×	30	538
Ruochen Qi China	9	127 1.1×	77 0.7×	160 1.7×	25 0.3×	55 0.8×	13	367
Yuki Takazawa Japan	9	230 1.9×	86 0.8×	238 2.5×	52 0.6×	97 1.5×	10	541
Wei-Fang Huang China	15	152 1.3×	65 0.6×	172 1.8×	28 0.3×	38 0.6×	24	470
Insa E. Emrich Germany	14	269 2.2×	86 0.8×	88 0.9×	37 0.4×	131 2.0×	42	616

Countries citing papers authored by Xuanyi Du

Since Specialization

Citations

This map shows the geographic impact of Xuanyi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuanyi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuanyi Du more than expected).

Fields of papers citing papers by Xuanyi Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuanyi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuanyi Du. The network helps show where Xuanyi Du may publish in the future.

Co-authorship network of co-authors of Xuanyi Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xuanyi Du. A scholar is included among the top collaborators of Xuanyi Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuanyi Du. Xuanyi Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Du, Xuanyi, Rui Zhang, Xue Li, et al.. (2025). Machine learning models for predicting short-term progression in patients with stage 4 chronic kidney disease: a multi-center validation study. Scientific Reports. 15(1). 39285–39285. 1 indexed citations

Chen, Sha, Yuanyuan Jia, Jing Sun, et al.. (2025). Polo-like kinase 1 drives hypoxia-induced renal fibrosis via PTEN/PGK1-mediated glycolytic activation. International Journal of Biological Macromolecules. 319(Pt 1). 145305–145305. 1 indexed citations

Jia, Yuanyuan, Jun Sun, Sha Chen, et al.. (2024). Dedicator of cytokinesis protein 2 activates the epithelial–mesenchymal transition in renal fibrosis through the Rac1/PI3K/AKT pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872(2). 119894–119894. 1 indexed citations

Sun, Jun, Yuanyuan Jia, Sha Chen, et al.. (2024). Adipose mesenchymal stem cell-derived extracellular vesicles alleviate renal fibrosis by reducing epithelial-mesenchymal transition via the FOXS1/Wnt/β-catenin signaling pathway. International Immunopharmacology. 146. 113880–113880. 1 indexed citations

Du, Xuanyi, et al.. (2024). #689 Obinutuzumab in patients with previously untreated primary membranous nephropathy. Nephrology Dialysis Transplantation. 39(Supplement_1).

Fu, Rao, Kexin Meng, Rui Zhang, Xuanyi Du, & Jundong Jiao. (2023). Bone marrow-derived exosomes promote inflammation and osteoclast differentiation in high-turnover renal osteodystrophy. Renal Failure. 45(2). 2264396–2264396. 2 indexed citations

Sun, Jing, et al.. (2023). Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria. Renal Failure. 45(1). 2188088–2188088. 5 indexed citations

Sun, Jing, et al.. (2022). Association of gut microbiota with idiopathic membranous nephropathy. BMC Nephrology. 23(1). 164–164. 13 indexed citations

Wei, Shi-Yao, Shuang Guo, Bei Feng, Shangwei Ning, & Xuanyi Du. (2021). Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis. BMC Nephrology. 22(1). 392–392. 7 indexed citations

10.

Zhou, Ping, et al.. (2020). Effect of parathyroid hormone-related protein on intracellular calcium ion and cyclic adenosine monophosphate concentrations in cardiac fibroblasts. Journal of International Medical Research. 48(9). 1220730797–1220730797. 2 indexed citations

11.

Du, Xuanyi, et al.. (2018). Impact of epigallocatechin‑3‑gallate on expression of nuclear factor erythroid 2‑related factor 2 and γ‑glutamyl cysteine synthetase genes in oxidative stress‑induced mouse renal tubular epithelial cells. Molecular Medicine Reports. 17(6). 7952–7958. 9 indexed citations

12.

Wu, Qiong, et al.. (2014). Co-administration of Wuzhi capsules and tacrolimus in patients with idiopathic membranous nephropathy: clinical efficacy and pharmacoeconomics. International Urology and Nephrology. 46(10). 1977–1982. 21 indexed citations

13.

Sheng, Weiqi, Dan Huang, Jianming Ying, et al.. (2013). HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance. Annals of Oncology. 24(9). 2360–2364. 84 indexed citations

14.

Kaneko, Tomohiro, Akira Shimizu, Akiko Mii, et al.. (2013). Role of Matrix Metalloproteinase-2 in Recovery after Tubular Damage in Acute Kidney Injury in Mice. Nephron Experimental Nephrology. 122(1-2). 23–35. 24 indexed citations

15.

Du, Xuanyi, Akira Shimizu, Yukinari Masuda, et al.. (2012). Involvement of matrix metalloproteinase-2 in the development of renal interstitial fibrosis in mouse obstructive nephropathy. Laboratory Investigation. 92(8). 1149–1160. 89 indexed citations

16.

Masuda, Yukinari, Akira Shimizu, Takashi Arai, et al.. (2010). Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis. Laboratory Investigation. 90(10). 1468–1481. 12 indexed citations

17.

Kunugi, Shinobu, Akira Shimizu, Naomi Kuwahara, et al.. (2010). Inhibition of matrix metalloproteinases reduces ischemia-reperfusion acute kidney injury. Laboratory Investigation. 91(2). 170–180. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact